Pfizer Revenue 2010-2024 | PFE

Pfizer revenue for the twelve months ending June 30, 2024 was $55.165B, a 29.65% decline year-over-year.

  • Pfizer annual revenue for 2023 was $58.496B, a 41.7% decline from 2022.
  • Pfizer annual revenue for 2022 was $100.33B, a 23.43% increase from 2021.
  • Pfizer annual revenue for 2021 was $81.288B, a 95.16% increase from 2020.

Pfizer Revenue 2010-2024 | PFE

  • Pfizer annual revenue for 2023 was $58.496B, a 41.7% decline from 2022.
  • Pfizer annual revenue for 2022 was $100.33B, a 23.43% increase from 2021.
  • Pfizer annual revenue for 2021 was $81.288B, a 95.16% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Sanofi (SNY)$133B
Innoviva (INVA)$953M